The cervical Total Disc Replacement (CTDR) device is used to treat patients suffering from Degenerative Disc Disorders (DDD). Neck pain is the major cause for the development of DDD in the cervical region of the spine. Cervical disc replacement surgery is performed for treatment of DDD, where the degenerated disc is removed surgically and an artificial disc is implanted in the vertebra. This is a Minimal Incision Surgery (MIS) and results in quick recovery post-surgery, short hospital stay, and low revision surgery rate.
Conventionally, DDD is treated through spinal fusion surgery, but due to the high rate of revision surgery and increasing the prevalence of adjacent segment disc degeneration post fusion surgery, doctors prefer cervical disc replacement over spinal fusion. Major players in the market are proactively providing training to spine surgeons, thus, ensuring efficient handling of their respective products.
Growing ageing population, low revision surgery rate, and increasing demand for advanced innovative CTDR devices for treatment of both class I and class II degenerative disc diseases, are major factors fueling demand for CTDR devices. Major trends witnessed in the CTDR device market include technological advancements, consistent investment in research and development activities, the and the surge in acquisitions and mergers.
The CTDR device market is segmented as follows:
This report covers the global CTDR device market performance in terms of revenue contribution. This section also includes PMR’s analysis of key trends, drivers, restraints, and opportunities, which are influencing the growth of the global CTDR device market currently. Impact analysis of key drivers and restraints is included in this report to better equip clients with crystal clear decision-making insights. The report also provides regional company share analysis and product details in terms of marketing approvals.
By material type, the global CTDR device market is segmented into metal on a biocompatible material (M-o-B) and metal on metal (M-o-M). Of these, metal on biocompatible material segment holds majority market share currently and is expected to remain the leading segment in terms of volume and value during the forecast period. The metal on a metal segment is projected to grow in terms of value and volume, but at a relatively slower pace compared to the metal on the biocompatible material segment. The number of products in the metal on the biocompatible material segment is higher compared to the metal on a metal segment, which is a major driver for the growth of the metal on the biocompatible material segment. Various benefits offered by metal on biocompatible material products such as greater degree of rotation and flexible movement of a spine are expected to drive the growth of this segment during the forecast period.
On the basis of the end user, the global CTDR device market is segmented into hospitals and ASCs. The hospitals segment dominated the CTDR device market in 2014; however, the ASCs segment is projected to expand at a higher CAGR over the forecast period as compared to the hospital segment. This is attributed to the fact that cervical disc replacement is a minimally invasive surgery and can be performed in ASCs. Number of patients undergoing cervical disc replacement in ASCs is increasing substantially due to factors such as quick discharge and their cost effectiveness, which in turn is expected to fuel growth of CTDR device market in the ASCs segment.
By region, North America is expected to remain dominant in the CTDR device market mainly due to robust reimbursement policies and rise in the number of cervical disc replacement procedures performed in the region. Prevalence of neck pain is comparatively higher in Western Countries as compared to APAC. In terms of growth rate, the APAC market is projected to grow at a significant pace mainly due to the large population base in the region. Revenue contribution from the market in North America, followed by markets in APAC and Europe, is expected to expand at the highest CAGR during the forecast period. The market in the MEA remains untapped, thus offering potential opportunities to companies operating in this industry.
Cervical total disc replacement (CTDR) device is used to treat patients suffering from degenerative disc disorders (DDD). Neck pain is the major cause for development of DDD in cervical region of the spine. Cervical disc replacement procedures is performed for treatment of DDD, where the degenerated disc is removed surgically and an artificial disc is implanted in the vertebra. This is a minimal incision surgery (MIS) and results in quick recovery post-surgery, short hospital stay and low revision surgery rate. Various benefits of this procedure is increasing adoption rate of this surgery over conventional spinal fusion surgery. Conventionally, DDD is treated through spinal fusion surgery, but due to high rate of revision surgery and increasing prevalence of adjacent segment disc degeneration post fusion surgery, doctors are considering cervical disc replacement over spinal fusion.
Growing ageing population, low revision surgery rate of cervical disc replacement surgery and increasing demand for advanced innovative CTDR device for treatment of both class I and class II degenerative disc disease are major factors leading to increased demand for CTDR devices, thereby fuelling growth of the CTDR device market.
Major trends in the CTDR device market include technological advancements with regard to CTDR device, consistent investment in research and development and surge in acquisitions and mergers.
The global total disc replacement market was valued at US$ 614.4 Mn in 2014. The CTDR device market accounted for 66% of global total disc replacement market in 2014, and was valued at US$ 409.7 Mn. Revenue contribution by CTDR device market to the global total disc replacement market is expected to increase to US$ 1,750.1 by the end of 2021, expanding at a CAGR of 23.1% during 2015–2021. Increasing prevalence of chronic diseases and growing ageing population are factors expected to positively affect growth of the CTDR device market across the globe.
Key market players covered in this report are Medtronic, plc, Depuy Synthes, Globus Medical, Inc., NuVasive, Inc., LDR Holding Corporation. Major players in CTDR device market focus on enhancing their global and regional presence through strategic acquisitions and mergers, and operational expansion.
Some key market players included in this report:
These companies have been profiled on the basis of various attributes such as company overview, recent developments, growth strategies, and financial overview.